INVO Fertility

INVO Fertility EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of INVO Fertility (IVF) as of Oct 19, 2026 is -5.84 M USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -7.14 M USD — a change of -18.24% (higher).

EBITDA

-5.84 MUSD

YoY

-18.24%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of INVO Fertility is 2025 -5.84 M USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of INVO Fertility was 2024 -7.14 M USD. It decreases by -18.24% higher compared to the previous year.

The INVO Fertility EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-2.63 M USD
Jan 1, 2019
-1.79 M USD
Jan 1, 2020
-5.51 M USD
Jan 1, 2021
-5.38 M USD
Jan 1, 2022
-10.83 M USD
Jan 1, 2023
-6.88 M USD
Jan 1, 2024
-7.14 M USD
Jan 1, 2025
-5.84 M USD
The INVO Fertility EBITDA history
YEAREBITDAYoY
-5.84 MUSD-18.24%
-7.14 MUSD+3.82%
-6.88 MUSD-36.47%
-10.83 MUSD+101.12%
-5.38 MUSD-2.36%
-5.51 MUSD+208.43%
-1.79 MUSD-32.12%
-2.63 MUSD+311.30%
-640,421.00USD-69.65%
-2.11 MUSD+254.65%
-595,074.00USD-64.59%
-1.68 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

INVO Fertility Stock analysis

What does INVO Fertility do? INVO Fertility Inc, trading under ticker IVF, is a U.S. company headquartered in Lakewood Ranch. It operates in the Health Care sector with a focus on fertility services. The company has 15 employees and went public on November 11, 2008. Its flagship product is INVOcell, a medical device enabling in vivo fertilization and embryo development. The INVOcell utilizes the intravaginal culture technique (IVC) for incubating oocytes and sperm during fertilization and early embryo development. The company operates three INVO Centers in North America. INVO Fertility is one of the most popular companies on Eulerpool.

Frequently Asked Questions about INVO Fertility stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of INVO Fertility is -5.84 M USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of INVO Fertility changed from -7.14 M USD to -5.84 M USD, representing a -18.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) INVO Fertility since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INVO Fertility historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — INVO Fertility

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — INVO Fertility